Proteasome Inhibitor Bortezomib Suppresses Nuclear Factor-Kappa B Activation and Ameliorates Eye Inflammation in Experimental Autoimmune Uveitis

Bortezomib is a proteasome inhibitor used for hematologic cancer treatment. Since it can suppress NF-κB activation, which is critical for the inflammatory process, bortezomib has been found to possess anti-inflammatory activity. In this study, we evaluated the effect of bortezomib on experimental au...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Sheng-Min, Yang, Chang-Hao, Shen, Fang-Hsiu, Chen, Shun-Hua, Lin, Chia-Jhen, Shieh, Chi-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306382/
https://www.ncbi.nlm.nih.gov/pubmed/25653480
http://dx.doi.org/10.1155/2015/847373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306382/
https://www.ncbi.nlm.nih.gov/pubmed/25653480
http://dx.doi.org/10.1155/2015/847373

Ejemplares similares